GENE ONLINE|News &
Opinion
Blog

Cell and Gene Therapy
In-Depth
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
Trials & Approvals CAR T-cell Therapy
First and Only CAR T Therapy for Mantle Cell Lymphoma Gets FDA Nod
2020-07-30
New Frontiers in Therapeutics
2020-07-25Partner
A Rising Hope in Therapeutics — From Precision Medicine to Advanced Therapies
2020-07-19
BIO Digital 2020 Highlights: Challenges in Bringing New Cell and Gene Therapies to Market
2020-06-23
R&D Multiple Sclerosis
Breakthrough Stem Cell Therapy Research Shows Repair in Multiple Sclerosis Damage
2020-05-24
Trials & Approvals
ASGCT20: Intellia Presents Data on Two of its CRISPR-Based Novel Therapeutic Candidates
2020-05-16
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
R&D Rare Disease
Mochida Pharma, Gene Techno Science Collaborate to Develop Regenerative Medicine for Rare Disease
2020-03-28
COVID-19
Update On 2019 Novel Coronavirus (2019-nCov): The Latest Progress In Vaccine Development And Treatment
2020-01-30
Taiwan
Weekly Cover: LATEST Cell Therapy Trend in Taiwan& 2019-nCoV Outbreak
2020-01-23
R&D
Gene Editing Companies to Exchange Patented Tech to Develop Cancer Therapies
2019-10-28
PD-L1
Weekly in Asia｜Oct-1
2019-10-14
Weekly in Asia 2019｜AUG-2
2019-08-03
Startups
Philadelphia-based Stem cell startup secures US$250 million funding
2019-07-09
1 2 3 4 5
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top